Candesartan Spirig HC 8 mg, Tabletten - 28 Swissmedic Key 66096002 Registration Holder Spirig HealthCare AG Name Candesartan Spirig HC 8 mg, Tabletten Date of registration 04.08.2016 Introduction of Sequence 04.08.2016 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 28 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 6.75 Deductible k.A. Consumer price 15.95 Feedback FB Daily cost GTIN 7680660960024 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 8 mg, maydis amylum, lactosum monohydricum 129.80 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.4 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 8 mg
BAG: Active Agent Dose Candesartanum Cilexetil 8 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 129.8 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
